ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 21 Issue : 3
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial [Anatol J Cardiol]
Anatol J Cardiol. 2019; 21(2): 83-90 | DOI: 10.14744/AnatolJCardiol.2018.21447  

Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial

Xiaoming Liu1, Zuoming Yang3, Xiaokun Liu2, Qi Zhang2, Changqing Liu2, Quanle Han2, Jianhua Sun2
1Departments of General Practice, and Cardiology, Tangshan Gongren Hospital, Hebei Medical University; Tangshan-China
2Department of Cardiology, Tangshan Gongren Hospital, Hebei Medical University; Tangshan-China
3Department of Orthopedic Trauma, Tangshan Second Hospital; Tangshan-China

Objective: Intravascular ultrasound (IVUS) has developed as a preferable choice for optimizing the stenting procedures mainly because it will have good access to vessel size, lesion length, or severity accurately. However, it still remains unclear about the benefits of IVUS guidance in drug-eluting stent (DES) implantation for patients with unprotected left main coronary artery (ULMCA) stenosis. The aim of the present study was to evaluate the clinical outcomes with respect to IVUS-guided DES implantation for these patients.
Methods: A total of 336 consecutive patients from December 2010 to December 2015 were enrolled in the study. The patients were then randomly assigned into two groups: IVUS-guided group (n=167) and control group (n=169). The primary endpoint was the incidence of composite major adverse cardiac events (MACEs), including cardiac death, myocardial infarction (MI), and target vessel revascularization (TVR). The risk of stent thrombosis (ST) was chosen as the safety endpoint.
Results: After a 1-year follow-up, the occurrence of composite MACE in the IVUS-guided group was significantly lower than that in the control group (13.2% vs. 21.9%, p=0.031), which might mainly result from the significant reduction in the risk of cardiac death (1.8% vs. 5.9%, p=0.048). Dramatically, the risk of MI did not differ significantly between the two groups (11.4% vs. 13.6%, p=0.478), though a tended reduction in TVR was observed under IVUS guidance (4.2% vs. 8.9%, p=0.068). There was no statistical significance between the two groups with respect to the risk of target lesion revascularization (IVUS-guided vs. control: 1.2% vs. 3.0%, p=0.239) and ST (IVUS-guided vs. control: 1.2% vs. 3.0%, p=0.246).
Conclusion: The possible feasibility of IVUS-guided DES implantation for patients with ULMCA stenosis was supported by the present study. Larger and more powerful randomized trials were still warranted to research the whole benefits of IVUS guidance for these patients.

Keywords: intravascular ultrasound, unprotected left main coronary artery stenosis, drug-eluting stent implantation


Xiaoming Liu, Zuoming Yang, Xiaokun Liu, Qi Zhang, Changqing Liu, Quanle Han, Jianhua Sun. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial. Anatol J Cardiol. 2019; 21(2): 83-90

Corresponding Author: Xiaoming Liu, China


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright 2018 Turkish Society of Cardiology